Educational only. Not medical advice. Invite-only research preview.No PHI. Do not share patient names or identifying information (HIPAA).
MytoIntelligence
All targets

Molecular target

5-HT1A Receptor

Serotonin receptor implicated in mood, anxiety, and stress regulation. Partial-agonist activity is associated with anxiolytic effects.

10 drugs act here5 plants reach it via their compounds

Educational use only. This page summarizes published research and traditional-use records for educational purposes. It does not diagnose, treat, cure, or prevent any disease. Do not start, stop, or change medications based on this information. Discuss any decisions about therapies — pharmaceutical or botanical — with a qualified clinician who knows your medical history.

No PHI / HIPAA notice: Do not share Protected Health Information (PHI) of any patient on this site — including names, dates of birth, addresses, MRNs, or any identifying information. Use abstract case framing only. Sharing PHI with non-covered entities risks HIPAA violation regardless of platform capability.

Pharmaceutical agents

Drugs that act on 5-HT1A Receptor

These medications have 5-HT1A Receptor among their molecular targets. Sharing a target is a mechanistic relationship — it does not make any plant below an alternative to, or substitute for, these drugs.

Botanical connections

Plants whose compounds act on 5-HT1A Receptor

Each plant below contains a named compound documented to act on 5-HT1A Receptor. The compound and the reason for the connection are shown on every edge — a shared mechanism, not a therapeutic equivalence.

  • Cannabidiol (CBD)Non-psychoactive cannabinoid

    Negative allosteric modulator at CB1; agonist at 5-HT1A, TRPV1; modulates GABA-A. Potent CYP3A4/2C9/2C19 inhibitor — major source of pharmacokinetic interactions.

  • Triterpene glycosides (actein, cimicifugoside)Triterpene glycoside

    Modern mechanism understanding: serotonergic activity, NOT estrogen receptor binding. The confusion arose because the indication overlap with phytoestrogens (menopausal symptoms) was historically assumed to imply mechanism overlap — modern binding studies show no ER affinity.

  • LinaloolMonoterpene alcohol

    Preclinical studies report GABAergic modulation and serotonergic activity attributed in part to linalool; investigated as a major anxiolytic-relevant constituent of ylang-ylang essential oil.

  • N,N-Dimethyltryptamine (DMT)Tryptamine alkaloid

    Primary visionary psychoactive — 5-HT2A agonism is the mechanism shared with psilocybin and LSD. From Psychotria viridis (chacruna) leaf in classical ayahuasca, or Diplopterys cabrerana (chaliponga) in some preparations. Schedule I in the US.

  • NuciferineAporphine alkaloid

    D2 receptor antagonist with 5-HT1A/5-HT2A modulation — receptor-binding profile resembles atypical antipsychotics in vitro.

A shared molecular target shows how a botanical and a drug relate mechanistically. It is not evidence that one can replace the other. Educational summary only — discuss any medication decision with your clinician.